Trial intelligence / Profile preview

MicroRNAs for Bone Formation in Tooth Sockets

NCT02579187Phase 1Withdrawn

Start
Dec 2025
Primary completion
Sep 2030
Modality
Gene Editing, Gene Silencing, miRNA Mimics
Countries
1
01

Overview

Phase 1, randomised, double-blind trial of pSil-miR200c and PMIS-miR-200a in Alveolar ridge resorption (4 arms). Primary endpoint: Percent of mineralized tissue upon histomorphometric analysis at 16 weeks. Planned start Dec 2025; status: withdrawn.

02

Drugs

pSil-miR200cPMIS-miR-200a
03

Conditions

Alveolar ridge resorption

Beyond the preview

Go deeper on NCT02579187.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02579187.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call